Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
A definitive Bike Standoff: Decision in favor of Your Number one Ride - 2Innovative Versatility: Examples of overcoming adversity from Entrepreneurs
- 3UAE recalls some Nestle infant formula products, Qatar warns consumers
- 4An Extended time of Careful Nurturing: Individual Bits of knowledge on Bringing up Kids
- 5Top notch Feasting: A Manual for Worldwide Acclaimed Eateries
- Step by step instructions to Pick A Keep money with High Fixed Store Loan costs
- Shooting of MIT professor Nuno Loureiro has police searching for a suspect
- Damaged Shenzhou-20 spacecraft to return to Earth uncrewed for inspection
- Linda Hamilton, 69, says she doesn't want to 'chase longevity'
- How to watch 'A Charlie Brown Christmas' for less with this Apple TV Black Friday deal
- 5 Great and High Evaluated Scene Configuration Administrations For 2024
- Emergent Cold LatAm opens state-of-the-art cold storage hub in Guadalajara
- American tourists left stranded in the Caribbean following flight cancellations after airspace closed for Maduro operation
- Vote In favor of Feasible Way You Prescribe to Shop for Garments
